Shoulder PainNCT06191705
Urdu Translation, Validity and Reliability of Quick Disabilities of Arm, Shoulder & Hand (QuickDASH)
An observational study of Shoulder Pain, run by Foundation University Islamabad at 1 site in Pakistan.
Trial summary
The purpose of this study is to translate Quick Disabilities of Arm, Shoulder \& Hand (QuickDASH) into Urdu and determine the validity and reliability of the Urdu version of QuickDASH. Read more about this study
- Who is it for?
- Ages 19 to 44 years
- Conditions the study is for
- Shoulder Pain
- What is being tested?
- QuickDASH
- How many people
- 50 participants
- Where
- 1 sitePakistan
- Study dates
- Apr 2024to Dec 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 to 44 years
- All sexes
- Adult
Study population: Individuals with for shoulder, arm/wrist, or hand musculoskeletal injury/pain/symptoms.
Who may be able to join
- Individuals with for shoulder, arm/wrist, or hand musculoskeletal injury/pain/symptoms. Capable of understanding and completing the self-reported questionnaires. The exclusion criteria were the -
Who cannot join
- Presence of any systemic disease or any neurological disorder. The upper limb involvement is due to any recent surgery in less than 6 weeks.
- -
Trial locations and contacts
1 site in 1 country.
About this study
The purpose of this study is to translate Quick Disabilities of Arm, Shoulder \& Hand (QuickDASH) into Urdu and determine the validity and reliability of the Urdu version of QuickDASH.
- Conditions
- Shoulder Pain
- Being tested
- QuickDASH
- Medical subject headings
- Shoulder Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
QuickDASHDiagnostic test
Participants will be administered Urdu version of QuickDASH to collect data regarding Disabilities of Arm, Shoulder \& Hand twice with a time interval of 72 hours to determine validity and reliability.
| Study group | Role | What they receive |
|---|---|---|
| Individuals with Arm, Shoulder or Hand pain /symptoms. | Not described Receives: Diagnostic Test: QuickDASH |
What is being measured
The primary outcome is the main question the study is designed to answer.
QuickDASH
Quick Disabilities of Arm, Shoulder \& Hand (QuickDASH) is used to determine the Disabilities of Arm, Shoulder and Hand. A higher score signifies poor outcome.
Measured: 72 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jan 2024
- Study startApr 2024 (estimated)
- Primary completionDec 2024 (estimated)
- Study completionDec 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Shoulder PainStudies of the same condition, open and under way.
- More trials run by Foundation University IslamabadThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Foundation University Islamabad
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06191705
- Sponsor's protocol ID
- FUI/CTR/2023/26
- Status last verified
- Dec 2023
- First submitted
- 20 Dec 2023
- Last updated
- 5 Jan 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Jan 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Urdu Translation, Validity and Reliability of Quick Disabilities of Arm, Shoulder & Hand (QuickDASH)
- ClinicalTrials.gov ID
- NCT06191705
- Acronym / sponsor ID
- FUI/CTR/2023/26
- Conditions
- Shoulder Pain
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Foundation University IslamabadUniversity, hospital or other
- Study start
- Apr 2024 (estimated)
- Primary completion
- Dec 2024 (estimated)
- Study completion
- Dec 2024 (estimated)
- First posted
- 5 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to translate Quick Disabilities of Arm, Shoulder \& Hand (QuickDASH) into Urdu and determine the validity and reliability of the Urdu version of QuickDASH.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Individuals with Arm, Shoulder or Hand pain /symptoms. | – | Diagnostic Test: QuickDASH |
Who may qualify
- Ages
- 19 to 44 years
- Sex
- All
- Age groups
- Adult
- Study population
- Individuals with for shoulder, arm/wrist, or hand musculoskeletal injury/pain/symptoms.
Key inclusion criteria (1 listed)
- Individuals with for shoulder, arm/wrist, or hand musculoskeletal injury/pain/symptoms. Capable of understanding and completing the self-reported questionnaires. The exclusion criteria were the -
Key exclusion criteria (2 listed)
- Presence of any systemic disease or any neurological disorder. The upper limb involvement is due to any recent surgery in less than 6 weeks.
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| QuickDASHParticipants will be administered Urdu version of QuickDASH to collect data regarding Disabilities of Arm, Shoulder \& Hand twice with a time interval of 72 hours to determine validity and reliability. | Diagnostic test | Individuals with Arm, Shoulder or Hand pain /symptoms. |
Primary outcome
QuickDASH
Time frame: 72 hours
Quick Disabilities of Arm, Shoulder \& Hand (QuickDASH) is used to determine the Disabilities of Arm, Shoulder and Hand. A higher score signifies poor outcome.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Jan 2024.
- Individual participant dataSharing planned: No
Related trials for Shoulder Pain
Recruiting
Effects of Cervicothoracic Mobilization in Patients With Supraspinatus Tendinitis
Rotator Cuff Tendonitis
Recruiting
Hybrid mHealth and Telerehabilitation vs Conventional Physiotherapy for Subacromial Pain Syndrome
Subacromial Pain Syndrome
Not yet recruiting
Magnesium Sulphate as an Adjuvant in Combined Costoclavicular Block and Suprascapular Block Versus Interscalene Block for Ambulatory Shoulder Arthroscopy
Postoperative Pain, Shoulder Arthroscopy
Active, not recruiting
Effects of Injection Combined With Spencer Technique on Painful Frozen Shoulder
Frozen Shoulder
Not yet recruiting
Laser Therapy Versus Transcutaneous Electical Nerve Stimulation at Hemiplegic Shoulder Pain
Hemiplegic Shoulder Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Shoulder Pain, run by Foundation University Islamabad at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 5 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Muhammad Osama (+923325540436, osamadpt@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
QuickDASH (time frame: 72 hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2024.